An audit of appropriate use of blood products in adult patients in a Venezuelan General University Hospital

International Journal for Quality in Health Care

Volumn 11, Issue 5, 1999, Pages 391-395

  Martí Carvajal, Arturo Jose ^a   Muñoz Navarro, Sergio Rafael ^a   Peña Martí, Guiomar Elena ^a   Comunian, Gabriella ^a  

^a VLN 278 ^*

Author keywords

Audit; Haemotherapy; Odds; Risk; Transfusion

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PREVALENCE; PRIORITY JOURNAL; RISK; UNIVERSITY HOSPITAL; VENEZUELA;

ADULT; ANALYSIS OF VARIANCE; BLOOD TRANSFUSION; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SERVICES MISUSE; HOSPITALS, UNIVERSITY; HUMANS; LOGISTIC MODELS; MALE; MEDICAL AUDIT; QUALITY ASSURANCE, HEALTH CARE; RETROSPECTIVE STUDIES; VENEZUELA;

EID: 2442728245     PISSN: 13534505     EISSN: None     Source Type: Journal    
DOI: 10.1093/intqhc/11.5.391     Document Type: Article

References (39)

1. Sloaud EM, Pitt E, Klein HG. Safety of the blood supply. J. Am Med. Assoc 1995; 274: 1368-1373.
2. Williamson LM. How should the safety and efficacy of platelet transfusion be assured? Blood Review 1998; 12: 203-214.
3. Koistinen J. Cost effectiveness of blood transfusion. Vox Sang 1996; 70 (Suppl 3): 86-88.
4. Miller RD, von Ehrenburg W. Controversies in transfusion medicine: Indications for autologous and allogenic transfusion should be the same. Con. Transfusion 1995; 35: 450-452.
5. Moor ACE, Dubbelman TMAR, VanSteveninck J, Brand A. Transfusion-transmitted disease: risk, prevention and perspectives. Eur J Haematol 1999; 62: 1-18.
6. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. N Engl J Med 1999; 340: 438-447.
7. Simon TL, Alverson DC, AuBuchon J et al. Practice parameter for the use of red blood cell transfusions. Arch Pathol Lab Med 1998; 122: 130-138.
8. Vamvakas EC, Taswell HF. Mortality after blood transfusion. Transfus Med Rev 1994; 7: 267-280.
9. Audet AM, Goodnough LT. Practice strategies for elective red blood cell transfusion. Ann Intent Med 1992; 116: 403-406.
10. British Committee for Standards in Haematology. Guidelines for the use of fresh frozen plasma. Transfus Med 1992; 2: 57-63.
11. NIH Consensus Conference. Platelets transfusion therapy. J Am Med Assoc 1987; 257: 1777-1780.
12. College of American Pathologists. Practice parameter for the use of fresh-frozen plasma, cryoprecipitate and platelets. J Am Med Assoc 1994; 271: 777-781.
13. Mozes B, Epstein M, Ben-Bassat I et al. Evaluation of the appropriateness of blood and blood product transfusion using preset criteria. Transfusion 1989; 29: 473-476.
14. Schot J, Steenssens L. Blood usage review in a Belgian University Hospital. Int J Qual Health Care 1994; 6: 41-45.
15. Ghali WA. Palepu A, Paterson WG. Evaluation of red blood cell transfusion practices with the use of preset criteria. Can Med Assoc J 1994; 150: 1449-1454.
16. Metz J, McGrath KM, Copperchini ML et al. Appropriateness of transfusion of red cells, platelets and fresh frozen plasma. An audit in a tertiary care teaching hospital. Med J Aust 1995; 162: 572-573.
17. Grindon AJ, Tomasulo PS, Bergin JJ et al. The Hospital Transfusion Committee. Guidelines for improving practice. J Am Med Assoc 1985; 253: 540-543.
18. Gould SA, Forbes JM. Controversies in transfusion Medicine: indications for autologous and allogenic transfusion should be the same. Pro. Transfusion 1995; 35: 446-449.
19. NIH Consensus Conference. Perioperative red blood cell transfusion. J Am Med Assoc 1988; 260: 2700-2703.
20. Carson JL, Duff A, Berlin JA et al. Perioperative blood transfusion and postoperative mortality. J Am Med Assoc 1998; 279: 199-205.
21. Consensus Conference. Fresh-frozen plasma. Indications and risks. J Am Med Assoc 1985; 253: 551-553.
22. Blumberg N, Laczin J, Mellican A, Heal J, Arvan D. A critical survey of fresh-frozen plasma use. Transfusion 1986; 26: 511-513.
23. Barnette RE, Fish DJ, Eisenstaedt RS. Modification of fresh-frozen plasma transfusion practices through educational intervention. Transfusion 1930; 30: 253-257.
24. Slichter SL, Corash L, Schiffer CA et al. In Schechter GP, McArthur JR, eds, The Education Program of The American Society of Hematology, Orlando, Florida, 7-8 December, 1996: pp. 119-131.
25. McCullough J, Steeper TA, Connelly DP et al. Platelet utilization in a University Hospital. J Am Med Assoc 1988; 259: 2414-2418.
26. Ancliff PJ, Machin SJ. Trigger factors for prophylactic platelet transfusion. Blood Rev 1998; 12: 234-238.
27. Contreras M. Consensus conference on platelet transfusion. Final Statement. Blood Rev 1998; 12: 239-240.
28. Stehling L, Luban NLC, Anderson KC et al. Guidelines for blood utilization. Review. Transfusion 1994; 34: 438-448.
29. Strauss RG, Levy GJ, Sotelo-Avila C et al. National Survey of Neonatal Transfusion Practices: II. Blood Component Therapy. Pediatrics 1993; 91: 530-536.
30. Poses RM, Berlin JA, Noveck H et al. How you look determines what you find: Severity of illness and variation in blood transfusion for hip fracture. Am J Med 1998; 105: 198-206.
31. Toy P. Audit and education in transfusion medicine. Vox Sang 1996; 70: 1-5.
32. Pinkerton PH. Blood bank audit. J Clin Pathol 1995; 48: 283-286.
33. Mintz PD. Quality assessment and improvement of transfusion practices. Hematol Oncol Clin North Am 1995; 9: 219-232.
34. Soumerai SB, Salem-Schatz S, Avorn J et al. A controlled trial of educational outreach to improve blood transfusion practice. J Am Med Assoc 1993; 270: 961-966.
35. Barnette RE, Fish DJ, Eisenstaedt RS. Modification of fresh frozen plasma transfusion practices through educational intervention. Transfusion 1990; 30: 253-257.
36. Rosen NR Bates LH, Herod G. Transfusion therapy, improved patient care and resource utilization. Transfusion 1993; 33: 341-347.
37. Chaffin DJ. Effect of a transfusion medicine educational electronic mail program on transfusion ordering practices (abstract). Transfusion 1997; 37(Suppl): S82.
38. Oberman HA. Inappropriate use of fresh-frozen plasma. J Am Med Assoc 1985; 253: 556-557.
39. Lawrence VA, Birch S, Gafni A. The impact of new clinical guidelines on the North American Blood Economy. Transfus Med Rev 1994; 4: 232-241.